Controller adherence following hospital discharge in high risk children: A pilot randomized trial of text message reminders.
Administration, Inhalation
Adrenal Cortex Hormones
/ administration & dosage
Asthma
/ drug therapy
Bronchodilator Agents
/ administration & dosage
Child
Child, Preschool
Emergency Service, Hospital
Female
Hospitalization
Humans
Male
Medication Adherence
/ statistics & numerical data
Patient Compliance
Patient Preference
Pilot Projects
Reminder Systems
Remote Sensing Technology
/ methods
Severity of Illness Index
Socioeconomic Factors
Text Messaging
Mobile health
inhaled corticosteroids
medication adherence
trajectory modeling
Journal
The Journal of asthma : official journal of the Association for the Care of Asthma
ISSN: 1532-4303
Titre abrégé: J Asthma
Pays: England
ID NLM: 8106454
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
14
2
2018
medline:
19
11
2019
entrez:
14
2
2018
Statut:
ppublish
Résumé
To assess the feasibility of a mobile health, inhaled corticosteroid (ICS) adherence reminder intervention and to characterize adherence trajectories immediately following severe asthma exacerbation in high-risk urban children with persistent asthma. Children aged 2-13 with persistent asthma were enrolled in this pilot randomized controlled trial during an asthma emergency department (ED) visit or hospitalization. Intervention arm participants received daily text message reminders for 30 days, and both arms received electronic sensors to measure ICS use. Primary outcomes were feasibility of sensor use and text message acceptability. Secondary outcomes included adherence to prescribed ICS regimen and 30-day adherence trajectories. Group-based trajectory modeling was used to examine adherence trajectories. Forty-one participants (mean age 5.9) were randomized to intervention (n = 21) or control (n = 20). Overall, 85% were Black, 88% had public insurance, and 51% of the caregivers had a high school education or less. Thirty-two participant families (78%) transmitted medication adherence data; of caregivers who completed the acceptability survey, 25 (96%) chose to receive daily reminders beyond that study interval. Secondary outcome analyses demonstrated similar average daily adherence between groups (intervention = 36%; control = 32%, P = 0.73). Three adherence trajectories were identified with none ever exceeding 80% adherence. Within a high-risk pediatric cohort, electronic monitoring of ICS use and adherence reminders delivered via text message were feasible for most participants, but there was no signal of effect. Adherence trajectories following severe exacerbation were suboptimal, demonstrating an important opportunity for asthma care improvement.
Identifiants
pubmed: 29437489
doi: 10.1080/02770903.2018.1424195
pmc: PMC6123277
mid: NIHMS1503754
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Bronchodilator Agents
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
95-103Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000003
Pays : United States
Références
Health Psychol. 2015 May;34(5):514-21
pubmed: 25222087
Am J Respir Crit Care Med. 2003 Apr 15;167(8):1068-76
pubmed: 12684246
Med Care. 2013 Sep;51(9):789-96
pubmed: 23685406
J Asthma. 2002 Feb;39(1):47-54
pubmed: 11883739
Pediatrics. 2009 Dec;124(6):1513-21
pubmed: 19948623
J Pediatr Psychol. 2015 Jan-Feb;40(1):75-84
pubmed: 24365698
J Asthma. 1998;35(7):547-52
pubmed: 9777881
Pediatrics. 2016 Mar;137(3):e20150461
pubmed: 26912205
Arch Pediatr Adolesc Med. 2001 Oct;155(10):1111-5
pubmed: 11576005
Allergy. 2009 May;64(5):784-9
pubmed: 19183166
Paediatr Respir Rev. 2003 Dec;4(4):325-33
pubmed: 14629956
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):455-63
pubmed: 26778246
J Asthma. 2014 Jun;51(5):536-43
pubmed: 24506699
J Allergy Clin Immunol. 2014 Sep;134(3):547-553.e5
pubmed: 25091437
PLoS One. 2013;8(2):e55335
pubmed: 23460785
J Allergy Clin Immunol. 2000 Jan;105(1 Pt 1):83-90
pubmed: 10629457
J Pediatr Psychol. 2014 Nov-Dec;39(10):1097-103
pubmed: 25216661
JAMA. 2015 Oct 20;314(15):1561-2
pubmed: 26501530
J Asthma. 2009 Nov;46(9):921-7
pubmed: 19905919
Am J Respir Crit Care Med. 2004 Dec 15;170(12):1281-5
pubmed: 15374842
Am J Health Promot. 2015 May-Jun;29(5):314-23
pubmed: 25928816
J Asthma. 2010 Mar;47(2):198-201
pubmed: 20170329
J Allergy Clin Immunol. 2009 Jun;123(6):1199-206; quiz 1207-8
pubmed: 19501229
J Pediatr Psychol. 2008 Jul;33(6):590-611
pubmed: 18192300
Am J Respir Crit Care Med. 2010 Mar 15;181(6):566-77
pubmed: 20019345
Annu Rev Clin Psychol. 2010;6:109-38
pubmed: 20192788
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
J Allergy Clin Immunol. 2009 Jun;123(6):1209-17; quiz 1218-9
pubmed: 19447484
J Pediatr. 2014 Feb;164(2):300-5
pubmed: 24238863
JAMA. 2011 Apr 27;305(16):1669-76
pubmed: 21521848
J Pediatr. 2005 Feb;146(2):157-9
pubmed: 15689896
J Allergy Clin Immunol. 2014 Dec;134(6):1260-1268.e3
pubmed: 25062783
JMIR Res Protoc. 2017 Mar 27;6(3):e48
pubmed: 28347975
J Pediatr. 2015 May;166(5):1121-7
pubmed: 25641244
J Pediatr Psychol. 2014 Sep;39(8):918-31
pubmed: 24952359
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):446-54
pubmed: 24565615
J Dev Behav Pediatr. 2009 Dec;30(6):574-82
pubmed: 19996903
Lancet Respir Med. 2015 Mar;3(3):210-9
pubmed: 25617215